U2Bio Co., Ltd. (KOSDAQ:221800)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,850
0.00 (0.00%)
At close: Feb 26, 2026
636.63%
Market Cap 427.79B
Revenue (ttm) 25.59B
Net Income (ttm) -2.99B
Shares Out 15.93M
EPS (ttm) -265.81
PE Ratio n/a
Forward PE n/a
Dividend 100.00 (0.37%)
Ex-Dividend Date Dec 29, 2025
Volume 7,770,604
Average Volume 3,456,153
Open 25,700
Previous Close n/a
Day's Range 25,200 - 32,800
52-Week Range 2,850 - 32,800
Beta -0.12
RSI 70.69
Earnings Date n/a

About U2Bio

U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers specimen testing services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical Laboratories
Founded 2009
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 221800
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.